Literature DB >> 31176210

Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection.

Asako Murayama1, Haruka Momose2, Norie Yamada1, Yuji Hoshi3, Masamichi Muramatsu1, Takaji Wakita1, Ken Ishimaru4, Isao Hamaguchi2, Takanobu Kato5.   

Abstract

BACKGROUND: For the diagnosis of hepatitis B virus (HBV) infection, the detection and quantification of hepatitis B surface antigen (HBsAg) and HBV DNA are used. Several kits are available for this purpose, and there is a growing need for the evaluation of these kits because their performance may be affected by HBV genotype- or strain-specific polymorphisms. OBJECTIVES AND STUDY
DESIGN: In this study, we used International Standards and the established regional reference panel to evaluate the performance of two HBV DNA quantitative kits, five HBsAg qualitative kits, seven HBsAg quantitative kits and three rapid immune-chromatographic tests for HBsAg.
RESULTS: The quantification values of two HBV DNA quantitative kits exhibited excellent correlation. In the evaluation of HBsAg qualitative and quantitative kits, the titers of several specimens in the HBV-positive panel were below the detection limits of a few kits, and the specimens were determined as HBV-negative. Notably, the quantitative kit results exhibited low correlation values. However, when these data were analyzed for each genotype, the correlations improved. These results suggest that the HBsAg quantification data are influenced by HBV genotypes. The novel rapid immune-chromatographic test exhibited the comparable level of sensitivity to the HBsAg quantitative kits.
CONCLUSIONS: We evaluated the performance of kits for the detection of HBV infection. The HBV DNA quantification data correlated with an excellent agreement, whereas the HBsAg quantification data were affected by HBV genotype. Such evaluations will be useful for estimating the quality of currently available and new HBV assay kits, and for the quality control of these kits.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostics; Genotype; HBV; HBV DNA; HBsAg

Mesh:

Substances:

Year:  2019        PMID: 31176210     DOI: 10.1016/j.jcv.2019.05.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Easily purified baculovirus/insect-system-expressed recombinant hepatitis B virus surface antigen fused to the N- or C-terminus of polyhedrin.

Authors:  Leonardo A Silva; Brenda R Camargo; Ana Carolina Araújo; Taylice Leonel Batista; Bergmann M Ribeiro; Daniel M P Ardisson-Araújo
Journal:  Arch Virol       Date:  2021-11-28       Impact factor: 2.574

2.  N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B Virus.

Authors:  Asako Murayama; Norie Yamada; Yoshiki Osaki; Masaaki Shiina; Hussein Hassan Aly; Masashi Iwamoto; Senko Tsukuda; Koichi Watashi; Mami Matsuda; Ryosuke Suzuki; Tomohisa Tanaka; Kohji Moriishi; Tetsuro Suzuki; Hironori Nishitsuji; Masaya Sugiyama; Masashi Mizokami; Kunitada Shimotohno; Takaji Wakita; Masamichi Muramatsu; T Jake Liang; Takanobu Kato
Journal:  Hepatology       Date:  2020-10-31       Impact factor: 17.425

3.  Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).

Authors:  Haoua Tall; Pierrick Adam; Abdoul Salam Eric Tiendrebeogo; Jeanne Perpétue Vincent; Laura Schaeffer; Cassandre von Platen; Sandrine Fernandes-Pellerin; François Sawadogo; Alkadri Bokoum; Ghislain Bouda; Seydou Ouattara; Issa Ouédraogo; Magali Herrant; Pauline Boucheron; Appolinaire Sawadogo; Edouard Betsem; Alima Essoh; Lassané Kabore; Amariane Ouattara; Nicolas Méda; Hervé Hien; Andréa Gosset; Tamara Giles-Vernick; Sylvie Boyer; Dramane Kania; Muriel Vray; Yusuke Shimakawa
Journal:  Vaccines (Basel)       Date:  2021-06-01

4.  A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen?

Authors:  Ruifeng Yang; Liyan Cui; Yan Liu; Xu Cong; Ran Fei; Shuping Wu; Lai Wei
Journal:  Ann Transl Med       Date:  2020-05

5.  Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients.

Authors:  Hiroteru Kamimura; Hirofumi Nonaka; Masaya Mori; Taichi Kobayashi; Toru Setsu; Kenya Kamimura; Atsunori Tsuchiya; Shuji Terai
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.